These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6669569)

  • 41. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 42. Properties of delta-associated ribonucleic acid.
    Hoyer B; Bonino F; Ponzetto A; Denniston K; Nelson J; Purcell R; Gerin JL
    Prog Clin Biol Res; 1983; 143():91-7. PubMed ID: 6669587
    [No Abstract]   [Full Text] [Related]  

  • 43. A simple, rapid, and sensitive integrated protein microarray for simultaneous detection of multiple antigens and antibodies of five human hepatitis viruses (HBV, HCV, HDV, HEV, and HGV).
    Xu R; Gan X; Fang Y; Zheng S; Dong Q
    Anal Biochem; 2007 Mar; 362(1):69-75. PubMed ID: 17239337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 45. Interpretation of serological markers of hepatitis viruses.
    Irshad M
    Trop Gastroenterol; 1995; 16(4):4-10. PubMed ID: 8854948
    [No Abstract]   [Full Text] [Related]  

  • 46. [Epidemiologic study on the spread of the delta agent in our territory by analysis of the antigen in hepatic biopsy].
    Villari D; Raimondo G; Longo G
    Pathologica; 1984; 76(1043):341-6. PubMed ID: 6387601
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hepatitis B among Israeli diabetics].
    Hakim M; Kanter Y; Ben-Porath E; Barzilai D
    Harefuah; 1981 Sep; 101(5-6):99-102. PubMed ID: 7344994
    [No Abstract]   [Full Text] [Related]  

  • 48. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Non-A, non-B hepatitis virus: progress achieved].
    Carreño V
    Rev Clin Esp; 1982 Nov; 167(3):139-41. PubMed ID: 6819607
    [No Abstract]   [Full Text] [Related]  

  • 50. [Delta antigen-antibody system in hepatitis B].
    Brauman A; Eshchar J
    Harefuah; 1982; 103(12):369-70. PubMed ID: 7183494
    [No Abstract]   [Full Text] [Related]  

  • 51. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical studies of viral hepatitis--epidemiology, immunology and prevention].
    Ichida F
    Nihon Naika Gakkai Zasshi; 1986 Feb; 75(2):173-6. PubMed ID: 3711717
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of the cross-reactivity between hepatitis B and non-A, non-B viruses for the identification and detection of non-A, non-B 'e' antigen.
    Vitvitski L; Trepo C; Hantz O
    J Virol Methods; 1980; 1(3):149-56. PubMed ID: 6168643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viral hepatitis: practical approach.
    Reindollar RW; Schiff ER
    Compr Ther; 1982 Aug; 8(8):55-61. PubMed ID: 6813018
    [No Abstract]   [Full Text] [Related]  

  • 55. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 57. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatitis viruses].
    Trepo C
    Rev Prat; 1995 Jan; 45(2):161-7. PubMed ID: 7725016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methods for detection of the delta antigen and antibody in liver and serum.
    Crivelli O; Shih JW; Rizzetto M
    Prog Clin Biol Res; 1983; 143():121-6. PubMed ID: 6366802
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of delta agent in fulminant hepatitis in the Los Angeles area.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Prog Clin Biol Res; 1983; 143():235-6. PubMed ID: 6669579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.